| abstract |
vaccine administration methods, feline caliciviroses, and treatments for immunizing animals against feline paraovirus and feline herpes virus. The present invention relates to a vaccine for immunizing cats against feline viruses. The present invention also relates to a nucleic acid clone encoding the isolated feline calicivirus capsid protein. The present invention also relates to a live or dead vaccine comprising isolated feline calicivirus, a subunit vaccine comprising isolated feline calicivirus capsid protein, a nucleic acid vaccine comprising a clone nucleic acid clone. isolated feline calicivirus, and a recombinant virus vector vaccine comprising nucleic acid encoding the isolated feline calicivirus capsid protein. The present invention also relates to a method for identifying a feline calicivirus useful for producing a vaccine composition and assays for diagnosing cats infected with feline calicivirus. Also described is a method for immunizing animals, especially cats, against disease, in particular against feline calicivirus (Fcv). The method includes administering to a cat therapeutically effective amounts of the first and second fcv vaccine. The first vaccine is administered orally or parenterally (e.g., subcutaneously, intramuscularly, and others). the second vaccine is administered orally or orally n days after the first vaccine administration, where n is an integer from 3 to 120 inclusive. A third vaccine administration may also be given. The present invention also describes methods and materials for treating and immunizing vaccinated animals, and in particular cats against both feline fpv or parvovirus which was also called panleukopenia or fpl and against another feline disease, fhv or herpes virus which was also called virus. of feline rhinotracheitis. |